Drug Database
VE

verapamil (Verelan Chrono / Veralan / Veratensin)

✓ Approved

Takeda · CACNA1C · Small Molecule

What is verapamil?

verapamil is a small molecule developed by Takeda. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesVerelan Chrono, Veralan, Veratensin
CompanyTakeda
Drug ClassSmall Molecule
Molecular TargetCACNA1C
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

verapamil acts on 1 molecular target:

CACNA1Ccalcium voltage-gated channel subunit alpha1 C (CACNL1A1, CACNA1C-IT2)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

verapamil is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Vascular disordersHypertension✓ Approved

Related Research Articles

PubMedJournal of advanced research2026-06-01

Ca2+ signaling in chronic rhinosinusitis with nasal polyps: Deciphering mechanistic insights and future therapeutic targets.

Kalaji Zaina Z, Hamadi Iyad Said IS, Al-Waa Ahmad Munzer AM, Hamoudi Rifat R et al.

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a prevalent yet inadequately understood condition characterized by benign lesions originating from inflamed nasal sinuses. It impacts patients by inducing nasal obstruction, inflammation, and recurrent symptoms. The pathophysiological mechanisms underlying nasal polyposis are not fully elucidated, which constrains the efficacy of current therapeutic interventions such as intranasal corticosteroids (INCSs), functional endoscopic sinus surgery (FESS), and biologics, particularly in severe, treatment-resistant, or recurrent cases. Recent research indicates that calcium (Ca2+) channels, notably with the use of blockers like Verapamil, may provide therapeutic benefits by addressing these challenges, demonstrating promising outcomes without significant adverse effects. Nonetheless, the molecular mechanisms involving Ca2+-dependent signaling pathways in CRSwNP remain insufficiently characterized, with a paucity of studies examining their dysregulation and contribution to disease pathology. Consequently, identifying critical components involved in disruptions of Ca2+ signaling is of paramount importance. We aim to encourage further research into the role of Ca2+ signaling in nasal polyposis and to identify potential pathways and novel targets for innovative treatments. This review consolidates current knowledge concerning Ca2+ signaling in CRSwNP, highlighting the roles of various Ca2+ channels and their downstream signaling cascades in modulating key pathological and clinical outcomes that are uniquely characteristic of the disease. Furthermore, we provide novel in silico insights into the potential pathogenic role of KCa3.1 through its interactions with genes such as TRPM6, EGF, HRH1, BCL2A1, and CD209 in CRSwNP, an area that has not been previously examined. This implicates new components and explores potential targets for future therapeutic strategies.

PubMedJournal of medicinal chemistry2026-05-30

From Scaffold Optimization to a Promising Lead: Discovery of a Novel Roemerine Analogue, a Multichannel Antiarrhythmic with Low hERG Liability and Functional Restoration Capacity.

Wu Zhanpan Z, Wang Wenping W, Yang Chunyan C, Peng Lin L et al.

This study identified 6-24, a novel antiarrhythmic lead derived from the roemerine scaffold, which exhibited a distinctive multichannel blockade profile targeting Nav1.5 and Cav1.2, while demonstrating only weak inhibition of hERG. This gentle multitarget profile avoided excessive single-channel blockade associated with proarrhythmic drugs, conferring low QT prolongation risk, a key advantage over agents like verapamil. Patch-clamp and iPSC-cardiomyocyte MEA confirmed prolonged action potentials and reduced conduction velocity. Multielectrode mapping in isolated hearts further revealed that the compound dose-dependently prolonged ventricular activation time and reduced conduction velocity, accompanied by a decrease in the heart rate, without significantly altering the QTc interval. Pharmacokinetic analysis further established that this active concentration could be achieved clinically. Beyond electrophysiological modulation, 6-24 uniquely restored cardiac function in vivo, normalizing ventricular dimensions and hemodynamics. With integrated efficacy, safety, and functional restoration, 6-24 represented a promising multitarget candidate for ventricular arrhythmia therapy.

PubMedNatural product research2026-05-24

Chemical components from Uncaria gambir (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity.

Liu Wenyan W, Jin Song S, Wang Ziming Z, Li Xinyue X et al.

The endangered Uncaria gambir (W.Hunter) Roxb. (U. gambir) remains largely unexplored in chemical constituents and bioactivities. Therefore, fifteen compounds (1-15), comprising monoterpene indole alkaloids, lignans, flavonoids, triterpenoids, coumarins, and fatty acids, were isolated from this species. Their inhibitory effects against cell division cycle 25B (CDC25B) phosphatase and vasodilatory activities were then evaluated. Results showed that compound 1 (strictosamide) exhibited a notable inhibitory effect on CDC25B phosphatase, with the IC50 value of 5.4 μM, comparable to the positive control (Na3VO4). Compound 3 (3α-dihydrocadambine) effectively revealed strong vasodilatory activity with EC50 values of 2.4 μM and 2.1 μM, respectively, similar levels comparable to the positive control (verapamil). Interestingly, these activities of compounds 1 and 3 were evaluated for the first time in this work. Moreover, network pharmacology and molecular docking predicted compound 1 to correlate with the p53-Hippo-TGF-β antitumor signalling pathway and compound 3 with the cAMP/cGMP-PKG cardiovascular signalling pathway. This work provides preliminary experimental data for the development of potential lead compounds from U. gambir.

PubMedJACC. Case reports2026-05-22

Idiopathic Left Ventricular Tachycardia in an 11-Year-Old Boy.

DeLong Adam A, Flaherty Michael M, Balaguru Duraisamy D

Electrocardiogram demonstrating idiopathic fascicular left ventricular tachycardia. An 11-year-old boy with a history of tuberous sclerosis-related intractable epilepsy exhibited an idiopathic ventricular tachycardia that was resistant to multiple antiarrhythmic treatments, but was responsive to verapamil. We discuss the recognition and treatment of verapamil-sensitive fascicular left ventricular tachycardia. Idiopathic fascicular left ventricular tachycardia in pediatric patients is an uncommon but recognizable arrhythmia. Its management differs from that of more commonly occurring pediatric wide-complex arrhythmias in that it readily responds to verapamil.

PubMedAnalytical methods : advancing methods and applications2026-05-22

An advanced GC method for comprehensive residual solvent analysis: overcoming co-elution with orthogonal columns and quantification by mass spectrometry.

Arulraj Ruba R, Vishwanath Vinay V, Duche Sharad S, Mathur Arvind A et al.

A robust and comprehensive gas chromatographic method was developed to identify and quantify the 57 residual solvents listed in the ICH guidelines, all in a single, 30-minute chromatogram. The proposed approach, featuring dual orthogonal column chemistry and a mass spectrometry (MS) detector, significantly improved the resolution and enabled the quantification of low-response and co-eluting solvents such as benzene, chloroform, formamide, pyridine, and 1,2-dichloroethene in a complex matrix of 57 solvents. The VF-624 and HP-5 dual-column was configured in series with an MS detector. Method parameters, such as carrier gas flow rate, oven temperature program, and selection of optimal mass spectrometry acquisition parameters, scan and selected ion monitoring (SIM), were tuned to achieve uncompromised sensitivity, resolution, and reproducibility. The method was validated according to ICH Q2(R1) guidelines and demonstrated acceptable specificity, linearity (R2 > 0.99), accuracy, precision, LOD, and LOQ. The real sample applicability was confirmed through analysis of a spiked fenoterol hydrobromide sample, establishing the method's robustness and suitability for testing the 57 residual solvents in pharmaceutical matrices. Additional evaluation with verapamil hydrochloride, amitriptyline hydrochloride, and their commercial formulations (tablets) further validated its broad applicability.

PubMedHealth science reports2026-05-18

The Potential Role of Verapamil Against Fluconazole-Induced Torsade de Pointes: A Critical Review.

Abdel-Razik Noha E NE, Al-Kuraishy Hayder M HM, Al-Gareeb Ali I AI, Soliman Maryam Magdy MM et al.

Fluconazole (FZL) is a broad-spectrum antifungal drug associated with certain serious adverse effects such as polymorphic ventricular arrhythmia due to QT prolongation. Torsade de Pointes (TdP) is a unique type of polymorphic ventricular arrhythmia due to QT prolongation. It has been shown that the calcium-channel blocker verapamil is effective in the management of TdP. Therefore, the present critical review aims to discuss and explain the possible role of verapamil in the prevention of FZL-induced TdP. Databases of Scopus, Cochran, Embase, PubMed, and CENTRAL were examined to recognize suitable publications. Screened articles were designated rendering to exact eligibility criteria including original articles such as prospective and retrospective studies recognizing the role verapamil in the prevention of FZL-induced TdP. The use of FZL is linked with the development of TdP and prolongation of QT, and verapamil use could be effective in the management of TdP. In addition, verapamil has antifungal effects, affects the pharmacokinetics and pharmacodynamics of FZL. Verapamil inhibits the propagation of TdP by inhibiting the deregulation of repolarization early after depolarization in the heart. This critical review suggests that combination of verapamil with FZL leads to more beneficial effects by increasing the antifungal activity of FZL with a significant reduction the development of TdP which is a serious adverse effect of FZL.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about verapamil